This comprehensive bill, known as the "Cannabis Administration and Opportunity Act," aims to federally decriminalize cannabis by removing it from Schedule I of the Controlled Substances Act. This descheduling is retroactive, applying to past offenses, and mandates the expungement of federal cannabis convictions and juvenile delinquency adjudications, with provisions for immediate release for eligible individuals. The legislation also makes conforming amendments to various federal laws, including those related to federal employee testing and transportation regulations, while preserving state and tribal authority to regulate or prohibit cannabis within their jurisdictions. Federal regulatory oversight for cannabis products would shift from the Drug Enforcement Administration to the Department of Health and Human Services (HHS) and the Department of the Treasury. The Alcohol and Tobacco Tax and Trade Bureau (TTB) would be redesignated to include cannabis, overseeing permits for import, manufacture, and wholesale, and establishing rules against unfair competition and unlawful trade practices. The Food and Drug Administration (FDA) would establish a Center for Cannabis Products to regulate product safety, labeling, manufacturing practices, and recalls, including a prohibition on flavored electronic cannabis delivery systems. A significant focus of the bill is restorative justice and economic opportunity for communities harmed by past cannabis prohibition. It establishes an Opportunity Trust Fund , financed by new federal excise taxes on cannabis products, to fund various programs. These include a Community Reinvestment Grant Program for job training, reentry services, legal aid for expungement, and youth programs in adversely impacted communities. The bill also creates a Cannabis Restorative Opportunity Program to provide Small Business Administration (SBA) loans and technical assistance to small businesses owned by socially and economically disadvantaged individuals in eligible states or tribal jurisdictions. An Equitable Licensing Grant Program would help states and tribes minimize barriers to cannabis licensing and employment for individuals adversely impacted by the War on Drugs, such as waiving application fees and preventing license denials based on certain past cannabis convictions. Furthermore, it prohibits discrimination in federal public benefits and immigration decisions based on cannabis use or offenses. Extensive research and public health initiatives are mandated, including studies on the societal impact of legalization, biomedical research on cannabis's effects and efficacy, and public health surveillance. The bill allocates funding for awards to prevent underage cannabis use and for national media campaigns on cannabis use and impaired driving. It also directs the Department of Veterans Affairs and Indian Health Service providers to offer recommendations and opinions on veteran and patient participation in cannabis programs. To ensure fair access, the legislation addresses banking and financial services for cannabis-related legitimate businesses and service providers. It requires updated guidance for suspicious activity reports and encourages financial institutions to invest in low- or moderate-income areas affected by the War on Drugs. Additionally, it includes provisions for workplace health and safety, requiring OSHA guidance and grants for community-based education on worker rights in the cannabis industry, and establishes a Cannabis Products Advisory Committee to advise federal regulatory bodies.